GEN Exclusives

More »

GEN News Highlights

More »
Feb 1, 2007

Court Found Synthon IP Infringed Norvasc Patents

  • A court ruled against Synthon IP in a patent infringement case related to Pfizer’s hypertension drug, Norvasc. The Federal District Court in the Eastern District of Virginia found that Synthon IP obtained, by inequitable conduct, two U.S. patents covering a process and an intermediate compound used to make the active ingredient in the medication.

    Pfizer intends to seek attorneys' fees from Synthon.

    Pfizer reported the court ruled that Synthon had knowingly failed to disclose to the U.S. Patent Office Pfizer publications and other information it had in its possession that described the process Synthon sought to patent.



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Connectomics Advocacy

How might connectomics maintain lasting support?